Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ·Healthcare·Biotechnology
$67.75
-1.25%
Mkt Cap $3.50B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (17 analysts)
$103.00
Range $89.00 – $116.00
Implied Upside
+52.0%
Consensus $103.00 vs current $67.75
NASDAQ·Healthcare·Biotechnology
$67.75
-1.25%
Mkt Cap $3.50B
Buy
7
Hold
0
Sell
0
Price Target (17 analysts)
$103.00
Range $89.00 – $116.00
+52.0%
Consensus $103.00 vs current $67.75